Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults

Overview of attention for article published in Annals of Clinical Psychiatry (Taylor & Francis Ltd), September 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)

Mentioned by

policy: 3 policy sources

reddit: 1 Redditor

So far, Altmetric has seen 7 policy documents that reference this research output.

Attention deficit hyperactivity disorder: diagnosis and management : D: Pharmacological safety

Cited by National Institute for Health and Care Excellence (NICE) on 11 Sep 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Attention deficit hyperactivity disorder: diagnosis and management : C: Pharmacological efficacy and sequencing

Cited by National Institute for Health and Care Excellence (NICE) on 09 Mar 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Attention deficit hyperactivity disorder: diagnosis and management: Evidence review

Cited by National Institute for Health and Care Excellence (NICE) on 01 Sep 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Attention deficit hyperactivity disorder: diagnosis and management: Evidence review

Cited by National Institute for Health and Care Excellence (NICE) on 01 Sep 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity, including 3 additional policy documents.